Skip to content

Use of the Equimolar Mixture of Oxide Nitrous and Oxygen (EMONO) Associated With Audiovisuals in Children

Use of the Equimolar Mixture of Oxide Nitrous and Oxygen (EMONO) Associated With Audiovisuals During Peripheral Venous Access Insertion of Children Between 2-5 Years Old Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05435118
Acronym
EMONO
Enrollment
120
Registered
2022-06-28
Start date
2023-08-17
Completion date
2024-04-22
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child, Only, Nitrous Oxide, Nurse's Role, Pain, Acute

Brief summary

Children experience numerous painful experiences from nursing procedures: peripheral venous access placement is the main cause of procedural pain. As much as pharmacological and nonpharmacological tools are known, their application during venipuncture is not systematic by children's hospitals. Among pharmacological tools, the Equimolar Mixture of Nitrogen Protoxide and Oxygen (EMONO) provides adequate protection from procedural pain through inhalation of the gas mixture at least 3 minutes before the procedure. Literature reports that the combination of nonpharmacological distractive tools and pharmacological interventions increases their analgesic effect. The aim of the study is to measure children's cooperation during procedure (primary outcome), pain perception and side effects when EMONO is combined with audiovisuals compared with EMONO alone in peripheral venous access placement.

Interventions

OTHEREMONO + audiovisuals tool

EMONO + use of audiovisuals tool on smartphone or tablet

Sponsors

Azienda Socio Sanitaria Territoriale di Lodi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 5 Years
Healthy volunteers
No

Inclusion criteria

* Age between 2 years and 5 years and 364 days * Prescription for peripheral venous access placement * Parental consent for participation in the study * Presence of at least one parent in possession of a smartphone/tablet with the ability to connect to the Internet through Wi-Fi available to users * Absence of contraindications to the administration of EMONO reported in health records * Absence of facial pathology * Presence on duty of at least one experimental nurse trained in the use of EMONO

Exclusion criteria

* Age less than 2 years and more than 5 years and 364 days * No parental consent to participate in the study * Parents not in possession of a smartphone/tablet with the ability to connect to the internet through Wi-Fi available to users * Presence of contraindications to EMONO administration * Presence of facial pathology * Oxygen therapy * Presence of tracheostomy * Absence on duty of at least one experimental nurse trained in the use of EMONO

Design outcomes

Primary

MeasureTime frameDescription
collaboration30 minuteschildren cooperation during procedure assessed with Groningen Distress Rating Scale (Humphrey et al., 1992; Herd et al., 2006; Doumit et al., 2016)

Secondary

MeasureTime frameDescription
pain perception in 2 years-old children30 minutespain perceprion during procedure assessed with FLACC scale (Merkel et al., 1997)
pain perception in 3 to 5 years-old children30 minutespain perceprion during procedure assessed with Wong-Baker scale (Wong and Baker, 1988)
side effect 130 minutesvomiting during procedure Due to not available scales, numerical values from 0 (absence of sign) to 3 (presence of sign requiring medical intervention ) will be assigned to these signs
side effect 230 minutesgag reflex during procedure Due to not available scales, numerical values from 0 (absence of sign) to 3 (presence of sign requiring medical intervention ) will be assigned to these signs

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026